Status:
UNKNOWN
Familial Aortopathies and Cellular Exploration
Lead Sponsor:
Assistance Publique Hopitaux De Marseille
Conditions:
Familial Aortopathies
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The prevalence of hereditary aortic disease (HTAD), responsible for aneurysm or dissection, is estimated at 25%. Mutations in the ACTA2 gene represent the main cause of non-syndromic forms (10-21%). A...
Eligibility Criteria
Inclusion
- patient with a mutation in the ACTA2 gene
Exclusion
- patient under 18 years of age at the time of inclusion
Key Trial Info
Start Date :
June 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 1 2023
Estimated Enrollment :
3 Patients enrolled
Trial Details
Trial ID
NCT05401500
Start Date
June 1 2022
End Date
June 1 2023
Last Update
June 2 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Assistance Publique Hopitaux de Marseille
Marseille, France, 13005